Similar articles

• [First results of a new iron chelating agent in the treatment of post-transfusional hemochromatosis].

  Giraud P, Orsini A, Giraud F, Pinsard N. Giraud P, et al. Arch Fr Pediatr. 1965 Apr;22(4):463-8. Arch Fr Pediatr. 1965. PMID: 5826583 French. No abstract available.
• Clinical usefulness of iron chelating agents.

  Waxman HS, Brown EB. Waxman HS, et al. Prog Hematol. 1969;6:338-73. Prog Hematol. 1969. PMID: 4976246 Review. No abstract available.
• [Blood transfusion and monitoring. Post-transfusion hemochromatosis].

  Bastion Y. Bastion Y. Soins. 1996 Apr;(605):27-8. Soins. 1996. PMID: 8716246 French. No abstract available.
• [Idiopathic hemochromatosis. Therapeutics].

  Pergola F. Pergola F. Presse Med (1893). 1967 May 20;75(24):1221-2. Presse Med (1893). 1967. PMID: 4960744 French. No abstract available.
• Iron metabolism and chelation therapy in hemosiderosis.

  Graziano JH. Graziano JH. Curr Top Hematol. 1978;1:127-50. Curr Top Hematol. 1978. PMID: 400529 Review. No abstract available.